By Amina Niasse and Kunal Das Nov 9 (Reuters) – Hims & Hers Health said on Monday it will begin offering some unapproved peptide treatments in November after US regulators eased curbs, with plans to
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Lee Siwoo ends South Korea’s wait for gold at Dakar 2026, as Taiwan, China and Turkey top podium
VIDEO SHOWS: HIGHLIGHTS OF THE YOUTH OLYMPIC GAMES DAY 10 SHOTLIST AND SCRIP TO FOLLOW…
Chinese chip firms Denglin, Xinde open mixed in Hong Kong debuts
HONG KONG, Nov 10 (Reuters) - Shares of Chinese AI chip designer Suzhou Denglin Technology…
Comedian Russell Brand found guilty by UK court of rape and sexual assaults
(The Nov 5 story was republished in error. The inconvenience caused is regretted.) By Sam…
